Anästhesiol Intensivmed Notfallmed Schmerzther 2019; 54(05): 317-319
DOI: 10.1055/a-0861-4380
Topthema
Einführung
Georg Thieme Verlag KG Stuttgart · New York

Pulmonale Hypertonie

Thomas Hachenberg
Further Information

Publication History

Publication Date:
13 May 2019 (online)

Die pulmonale Hypertonie ist keineswegs eine seltene Erkrankung. Sie besteht definitionsgemäß bei

  • einem mittleren pulmonalarteriellen Druck ≥ 25 mmHg,

  • pulmonalarteriellem Verschlussdruck ≤ 15 mmHg und

  • pulmonalem Gefäßwiderstand > 3 Wood-Einheiten in Ruhe [1].

 
  • Literatur

  • 1 Hoeper MM, Ghofrani HA, Grünig E. et al. Pulmonary Hypertension. Dtsch Arztebl Int 2017; 114: 73-84
  • 2 Ahmed A, Akintoye E, Adegbala O. et al. In-hospital outcomes of transcatheter mitral valve repair with Mitraclip in patients with pulmonary hypertension: Insights from the National Inpatient Sample. Catheter Cardiovasc Interv 2018; DOI: 10.1002/ccd.27997.
  • 3 Pilkington SA, Taboada D, Martinez G. Pulmonary hypertension and its management in patients undergoing non-cardiac surgery. Anaesthesia 2015; 70: 56-70
  • 4 Meyer S, McLaughlin VV, Seyfarth HJ. et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J 2013; 41: 1302-1307
  • 5 Ramakrishna G, Sprung J, Ravi BS. et al. Impact of pulmonary hypertension on the outcomes of non-cardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005; 45: 1691-1699
  • 6 Shah AC, Ma K, Faraoni D. et al. Self-reported functional status predicts post-operative outcomes in non-cardiac surgery patients with pulmonary hypertension. PLoS One 2018; 13: e0201914